Xilis
Developer of micro-organ sphere technology designed to guide precision therapy for cancer patients and accelerate drug discovery. The company's platform enables rapid diagnostics, personalized drug sc...
Valuation
$57M
Market implied
Share Price
N/A
Total Raised
$114.7M
Last Round
N/A